RWM
RMD icon

Ritholtz Wealth Management’s ResMed RMD Stock Holding History

Ritholtz Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,801
Closed -$629K – 1372
2026
Q1 		$629K Buy
2,801
+42
+2% +$10.5K 0.01% 702
2025
Q4 		$665K Sell
2,759
-731
-21% -$187K 0.01% 630
2025
Q3 		$955K Buy
3,490
+900
+35% +$246K 0.02% 512
2025
Q2 		$668K Sell
2,590
-7,521
-74% -$1.79M 0.01% 556
2025
Q1 		$2.26M Buy
10,111
+7,582
+300% +$1.77M 0.07% 225
2024
Q4 		$578K Sell
2,529
-9,923
-80% -$2.39M 0.02% 524
2024
Q3 		$3.04M Buy
12,452
+9,941
+396% +$2.22M 0.09% 153
2024
Q2 		$481K Buy
+2,511
New +$509K 0.02% 541
2022
Q4 		– Sell
-1,160
Closed -$253K – 710
2022
Q3 		$253K Buy
+1,160
New +$264K 0.01% 595

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ritholtz Wealth Management's RMD Position: Q2 2026 in Review

Ritholtz Wealth Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 2,801 shares — an estimated $629K sold.

Ritholtz Wealth Management first reported a position in RMD in Q3 2022 and held it in 9 quarters. The position peaked at $3.04M in Q3 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ritholtz Wealth Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Ritholtz Wealth Management sold 2,801 ResMed shares in Q2 2026, an estimated $629K.
  • Ritholtz Wealth Management first reported a position in ResMed in Q3 2022 and held it in 9 quarters.
  • Ritholtz Wealth Management's ResMed position peaked at $3.04M in Q3 2024.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.